22909976[PMID] - PMC - NCBI

Result Filters

You searched 8+ million full text articles

Try this search in 34+ million citations and abstracts

PMC Full-Text Search Results

Items: 4

1.

Figure. From: K-Ras gene mutation status as a prognostic and predictive factor in patients with colorectal cancer undergoing irinotecan- or oxaliplatin-based chemotherapy.

Figure 4. Time to progression according to K-Ras gene mutation status.

Rafał Stec, et al. Cancer Biol Ther. 2012 Nov 1;13(13):1235-1243.

Citation Full text

2.

Figure. From: K-Ras gene mutation status as a prognostic and predictive factor in patients with colorectal cancer undergoing irinotecan- or oxaliplatin-based chemotherapy.

Figure 3. OS rates in patients with B-Raf gene mutations relative to those with wild-type gene.

Rafał Stec, et al. Cancer Biol Ther. 2012 Nov 1;13(13):1235-1243.

Citation Full text

3.

Figure. From: K-Ras gene mutation status as a prognostic and predictive factor in patients with colorectal cancer undergoing irinotecan- or oxaliplatin-based chemotherapy.

Figure 2. OS rates in patients with K-Ras gene mutations in codon 12 relative to codon 13.

Rafał Stec, et al. Cancer Biol Ther. 2012 Nov 1;13(13):1235-1243.

Citation Full text

4.

Figure. From: K-Ras gene mutation status as a prognostic and predictive factor in patients with colorectal cancer undergoing irinotecan- or oxaliplatin-based chemotherapy.

Figure 1. Overall survival (OS) rates in patients with K-Ras gene mutations relative to those with wild-type gene.

Rafał Stec, et al. Cancer Biol Ther. 2012 Nov 1;13(13):1235-1243.

Citation Full text

Supplemental Content

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

You are here: NCBI > Literature > PubMed Central (PMC)